Market Pulse
Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Chris Tobin, Senior Vice President at Alliant Public Entity, named 2026 Business Insurance Women to Watch honoree.
Read full analysis →
Trident’s joint venture, Trident Aliska Digital Tech Ghana Ltd (TADT), projects Sikaflow revenue run-rate of $65.5M annualized by December 2026.
Read full analysis →
Kenady Minley, Finance Manager at Court Street Ford, won the 2026 Ally Sees Her Award at the NAMAD Conference in Miami.
Read full analysis →
Evaxion will report its second quarter 2026 financial results on August 20, 2026.
Read full analysis →
Arintra's autonomous coding platform increased Vanova Health's average E/M level from 3.49 to 3.63 in six months.
Read full analysis →
Lumentum management will participate in five investor events between August 17 and September 10, 2026.
Read full analysis →
SoFi's THTA ETF declared a $0.13055 monthly distribution (10% annual rate) on August 14, 2026.
Read full analysis →
Associa earned the 2026 Great Place to Work Certification™ in the U.S. (10th consecutive year), Canada (7th year), and Mexico (5th year).
Read full analysis →
Allarity Therapeutics ended Q2 2026 with $26.9 million in cash and restricted cash.
Read full analysis →
American Fusion Inc. (OTC: AMFN) highlights $4.48 billion in fusion industry funding in the past year, up 69% YoY.
Read full analysis →
Lantheus Holdings received FDA approval for TAUKLARIFY (florquinitau F 18 injection), a tau PET imaging agent for Alzheimer’s disease evaluation on August 14, 2026.
Read full analysis →
Fully enrolled pivotal Phase 3 Alzheimer’s trial with 850 patients, exceeding original target of 760.
Read full analysis →
Phase 1 trials for GTB-3650 (CD33-positive leukemias) and GTB-5550 (B7H3-positive solid tumors) ongoing, with updates expected in 2H 2026.
Read full analysis →
SurgePays reported Q2 2026 revenue of $16.2M, up 40.7% YoY and first-half revenue of $32.19M, up 45.7% YoY.
Read full analysis →
Z Squared CEO David Halabu emphasizes power scarcity as the key bottleneck in AI infrastructure, not chips.
Read full analysis →
The National Police Association endorsed the Kelsey Smith Act, a federal bill allowing law enforcement immediate access to cellular location data in emergencies.
Read full analysis →
Nchacha Etta to become Executive Vice President and CFO of U.S. Physical Therapy effective September 1, 2026
Read full analysis →
Canopy Growth's Kincardine facility renewed its EU GMP certification from the Regierungspräsidium Tübingen.
Read full analysis →
Q2 2026 revenue grew 22% YoY to $2.8M, with medical segment up 231% on CompuFlo adoption
Read full analysis →
Edible Garden reported Q2 2026 revenue growth of 12.8% to $3.6 million, with total sales increasing 31.2% year-over-year.
Read full analysis →
